Delayed wound healing can cause significant issues for immobile and ageing individuals as well as those living with co-morbid conditions such as diabetes, cardiovascular disease, and cancer. Sustained innate immune activation and inflammation are common features observed across most chronic wound types. However, the factors driving this activation remain incompletely understood. Emerging evidence suggests that the composition and structure of the wound microbiome may play a central role in driving this dysregulated activation but the cellular and molecular mechanisms underlying these processes require further investigation. In this review, we discussed the current literature related to: 1) how bacterial populations and biofilms contribute to chronic wound formation, 2) the role of bacteria and biofilms in driving dysfunctional innate immune responses in chronic wounds, and 3) therapeutics currently available (or underdevelopment) that target bacteria-innate immune interactions to improve healing. We will also discuss potential issues in studying the complexity of immune-biofilm interactions in chronic wounds and explore future areas of investigation for the field.
Biofilm-Innate Immune Interface: Contribution to Chronic Wound Formation
SHARE THIS ON:
Research Area: Cell Biology, Disease Biology
BMP signaling in the intestinal epithelium drives a critical feedback loop to restrain IL-13-driven tuft cell hyperplasia
Although Helminth infections are prevalent throughout the world, they are particular a health...
LSD1 represses a neonatal/reparative gene program in adult intestinal epithelium
After birth, the epithelium that lines our gut transitions (or matures) so that it can deal...
Targeting mRNA binding proteins to respond to stress responses
The paper establishes the phosphorylation of heterogeneous nuclear ribonucleoprotein A1...